Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Katwijk Chemie is an independent, family-owned Dutch company that specializes in the production of Active Pharmaceutical Ingredients (APIs) and fine chemicals. Established in 1914, the company operates a GMP-compliant manufacturing facility in Katwijk, Netherlands, serving the global pharmaceutical industry. Their core expertise lies in the synthesis of small molecules, with a product portfolio that includes treatments for epilepsy, muscle relaxation, and respiratory conditions. Katwijk Chemie provides both generic APIs and custom synthesis services for proprietary drug manufacturers. The company is recognized for its long-term stability and commitment to high-quality chemical production standards. It maintains a strong presence in the international market, exporting products to numerous countries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Katwijk.